Whole Blood Specimen Collection From Pregnant Subjects
NCT02430584 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 5000
Last updated 2020-09-17
Summary
To obtain whole blood specimens from pregnant subjects to be used for research and development and clinical validation studies of prenatal assays.
Conditions
- Down Syndrome
- Edwards Syndrome
- Patau Syndrome
- Klinefelter Syndrome
- Turner Syndrome
- DiGeorge Syndrome
- Perinatal Infections
Interventions
- OTHER
-
Observational - no intervention
Sponsors & Collaborators
-
Progenity, Inc.
lead INDUSTRY
Eligibility
- Min Age
- 18 Years
- Sex
- FEMALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2015-03-31
- Primary Completion
- 2021-03-31
- Completion
- 2021-05-31
Countries
- United States
Study Locations
More Related Trials
-
Expanded Noninvasive Genomic Medical Assessment: The Enigma Study
NCT02787486 ·Status: COMPLETED
-
Development of New Prenatal Diagnostic Tests From Maternal Blood
NCT00314691 ·Status: TERMINATED ·Phase: NA
-
Development of an Optimal Approach to Return of Results for Next-generation Sequencing for Prenatal Diagnosis
NCT02255825 ·Status: WITHDRAWN ·Phase: NA
-
Prospective Collection of Whole Blood Specimens From RhD Negative Pregnant Women
NCT06690099 ·Status: RECRUITING
-
Non-Invasive Determination of Fetal Chromosome Abnormalities
NCT00891852 ·Status: UNKNOWN
-
Non Invasive Prenatal Testing (NIPT) of Single-gene Disorders
NCT02339402 ·Status: UNKNOWN
-
National Prevalence and Impact of Noninvasive Prenatal Testing
NCT02284399 ·Status: COMPLETED
-
Development of Non-invasive Prenatal Screening Test for Microdeletions Based on Fetal DNA Isolated From Maternal Blood
NCT01852708 ·Status: COMPLETED
-
Prenatal Test for Fetal Aneuploidy Detection
NCT01256606 ·Status: COMPLETED
-
Development of Non-invasive Prenatal Test for Microdeletion and Other Genetic Syndromes Based on Cell Free DNA
NCT02109770 ·Status: COMPLETED
-
Non-invasive Prenatal Diagnostic Validation Study
NCT01574781 ·Status: COMPLETED
-
Clinical Performance of the MaterniT21 PLUS LDT in Multiple Gestation Pregnancies
NCT02226315 ·Status: TERMINATED
-
Multiple Gestation Study
NCT02278536 ·Status: COMPLETED
-
Noninvasive Screening for Affected Pregnancies: Assay Development & Optimization in Affected Pregnancies
NCT01052688 ·Status: COMPLETED
-
Serum Concentrations of Pregnancy-associated Proteins for Assessment of Gestational Age Before Abortion
NCT04232189 ·Status: TERMINATED
-
Technology Development for Noninvasive Prenatal Genetic Diagnosis Using Whole Fetal Cells From Maternal Peripheral Blood
NCT04285814 ·Status: COMPLETED
-
Development of a Non-invasive Prenatal Test
NCT01451684 ·Status: COMPLETED
-
Clinical Evaluation of the SEQureDx T21 Test In High Risk Pregnancies
NCT01555346 ·Status: COMPLETED
-
Non Invasive Prenatal Test of Rare Genetic Diseases: Application to Rare Intellectual Disabilities
NCT03688594 ·Status: UNKNOWN ·Phase: NA
-
Non-invasive Placental Chromosome Exploration of Intrauterine Growth Restriction
NCT05023161 ·Status: RECRUITING
-
Prenatal Genetic Diagnosis by Genomic Sequencing
NCT03936101 ·Status: COMPLETED
-
Non-Invasive Screening for Fetal Aneuploidy: A New Maternal Plasma Marker
NCT00770458 ·Status: COMPLETED
-
Urine and Serum Concentrations of Pregnancy-Associated Compounds During Gestation
NCT03552055 ·Status: COMPLETED
-
A New Prenatal Blood Test for Down Syndrome
NCT00877292 ·Status: COMPLETED
-
Prenatal Non-invasive Aneuploidy Test Utilizing SNPs Trial
NCT01545674 ·Status: TERMINATED